Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA NATCO PHARMA TORRENT PHARMA/
NATCO PHARMA
 
P/E (TTM) x 58.9 13.3 441.8% View Chart
P/BV x 14.2 3.5 406.2% View Chart
Dividend Yield % 0.8 0.6 146.3%  

Financials

 TORRENT PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
NATCO PHARMA
Mar-23
TORRENT PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,723847 203.5%   
Low Rs1,243502 247.5%   
Sales per share (Unadj.) Rs284.2148.4 191.6%  
Earnings per share (Unadj.) Rs36.839.2 93.9%  
Cash flow per share (Unadj.) Rs57.748.2 119.7%  
Dividends per share (Unadj.) Rs22.005.50 400.0%  
Avg Dividend yield %1.50.8 181.9%  
Book value per share (Unadj.) Rs183.1267.1 68.6%  
Shares outstanding (eoy) m338.45182.47 185.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.24.5 114.8%   
Avg P/E ratio x40.317.2 234.2%  
P/CF ratio (eoy) x25.714.0 183.7%  
Price / Book Value ratio x8.12.5 320.7%  
Dividend payout %59.814.0 426.2%   
Avg Mkt Cap Rs m501,779123,049 407.8%   
No. of employees `000NANA-   
Total wages/salary Rs m16,7774,867 344.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m96,20227,071 355.4%  
Other income Rs m6321,285 49.2%   
Total revenues Rs m96,83428,356 341.5%   
Gross profit Rs m28,2409,117 309.7%  
Depreciation Rs m7,0661,638 431.4%   
Interest Rs m3,334145 2,299.6%   
Profit before tax Rs m18,4728,619 214.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,0191,466 410.6%   
Profit after tax Rs m12,4527,153 174.1%  
Gross profit margin %29.433.7 87.2%  
Effective tax rate %32.617.0 191.6%   
Net profit margin %12.926.4 49.0%  
BALANCE SHEET DATA
Current assets Rs m53,13730,003 177.1%   
Current liabilities Rs m54,4736,831 797.4%   
Net working cap to sales %-1.485.6 -1.6%  
Current ratio x1.04.4 22.2%  
Inventory Days Days1563 24.4%  
Debtors Days Days7115 6.4%  
Net fixed assets Rs m91,39026,571 343.9%   
Share capital Rs m1,692365 463.6%   
"Free" reserves Rs m60,28848,373 124.6%   
Net worth Rs m61,98148,738 127.2%   
Long term debt Rs m24,9620-   
Total assets Rs m144,68256,574 255.7%  
Interest coverage x6.560.4 10.8%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.70.5 139.0%   
Return on assets %10.912.9 84.6%  
Return on equity %20.114.7 136.9%  
Return on capital %25.118.0 139.5%  
Exports to sales %21.80-   
Imports to sales %010.2 0.0%   
Exports (fob) Rs m20,994NA-   
Imports (cif) Rs mNA2,772 0.0%   
Fx inflow Rs m20,99417,256 121.7%   
Fx outflow Rs m3,7352,772 134.8%   
Net fx Rs m17,25914,484 119.2%   
CASH FLOW
From Operations Rs m23,6818,491 278.9%  
From Investments Rs m-24,153-4,771 506.2%  
From Financial Activity Rs m774-3,630 -21.3%  
Net Cashflow Rs m1,101208 529.5%  

Share Holding

Indian Promoters % 71.3 49.7 143.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.3 25.0 85.3%  
FIIs % 14.1 13.7 102.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.8 50.3 57.2%  
Shareholders   69,117 207,571 33.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Torrent Pharma vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Torrent Pharma vs Natco Pharma Share Price Performance

Period Torrent Pharma Natco Pharma S&P BSE HEALTHCARE
1-Day 1.45% -2.11% 1.18%
1-Month -0.30% -3.19% -0.75%
1-Year 68.52% 72.80% 61.82%
3-Year CAGR 27.16% 4.96% 18.16%
5-Year CAGR 21.87% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the Torrent Pharma share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Torrent Pharma hold a 71.3% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Torrent Pharma and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Torrent Pharma paid a dividend of Rs 22.0 per share. This amounted to a Dividend Payout ratio of 59.8%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of Torrent Pharma, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.